V74-14614-53111
2 vaccinations
2 coded responses
15 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 290 / SC
- Registered
- 2021-07-18
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-16
Dose 1 — Pfizer-BioNTech
-
2021-07-18
Registered in v-safe
- 2021-07-18
-
2021-07-19
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-07-20
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Muscle or body aches, NauseaAdult check-in
- 2021-07-21
- 2021-07-23
- 2021-07-30
-
2021-08-06
Dose 2 — Pfizer-BioNTech
- 2021-08-07
- 2021-08-09
- 2021-08-15
- 2021-08-20
-
2021-08-29
Survey response — day 21, dose 2MedDRA: Fatigue, Headache, Myalgia, Nausea — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Headache Fatigue Muscle acheNauseaMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-09-12
- 2021-11-05
-
2022-02-04
Survey response — 6 months, dose 2MedDRA: Abortion spontaneous, Pruritus — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Miscarriage Itching in hands and feetMedDRA releases: 2024-11 · check-in free text available
-
2022-02-04
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-02-08
- 2022-02-11
- 2022-08-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-16 | Pfizer-BioNTech | No |
| 2 | 2021-08-06 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-04 | Unsuccessful |
Free text
Release 9 — day 21, dose 2
Symptoms: Headache Fatigue Muscle acheNausea
Release 11 — 6 months, dose 2
Symptoms: Miscarriage Itching in hands and feet
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Fatigue | ✓ | · | ✓ |
| SD | Headache | ✓ | · | ✓ |
| SD | Myalgia | ✓ | · | ✓ |
| SD | Nausea | ✓ | · | ✓ |
| SD | Pruritus | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release